INmune Bio raises ~$19M in registered direct offering of 3M shares at $6.30/sh

Inmune Bio, Inc.

Offering of 3,000,000 common shares at $6.30/share to two healthcare-focused institutional investors.
Gross proceeds of approximately $19 million; net proceeds for working capital and general corporate purposes.
A.G.P./Alliance Global Partners acted as sole placement agent; 7% cash fee paid.
Pricing announced June 27, 2025; closing occurred June 30, 2025.
Shares offered under effective shelf registration statement (Form S-3, File No. 333-279036).

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.